Study of Durvalumab With Chemoradiotherapy for Women With Locally Advanced Cervical Cancer (CALLA)

Condition:   Locally Advanced Cervical Cancer Interventions:   Biological: Durvalumab;   Drug: Cisplatin;   Drug: Carboplatin;   Radiation: external beam radiation therapy (EBRT) + brachytherapy Sponsor:   AstraZeneca Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials